Jasreman Dhillon

9PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesCell physiologySemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

|Jan 22, 2026
Intraepithelial Penile Lesions.

Hongzhi Xu, Jasreman Dhillon

|Jan 22, 2026
Evaluating the Performance of the Paris System in Neobladder Cytology: The Role of Cellularity and Volume Adequacy Criteria.

Atousa Ordobazari, Reza Nikfar, Xing Zhao

|May 14, 2025
Current practices in prostate pathology reporting: results from a survey of genitourinary and general pathologists.

Mahra Nourbakshs, Liping Du, Andres M Acosta

|Apr 29, 2025
REASONING BEYOND ACCURACY: EXPERT EVALUATION OF LARGE LANGUAGE MODELS IN DIAGNOSTIC PATHOLOGY.

Asim Waqas, Asma Khan, Zarifa Gahramanli Ozturk

|Nov 09, 2024
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

Roger Li, Nancy Y Villa, Xiaoqing Yu

Pageof 2

Frequent Collaborators

3 joint publications

Xuefeng Wang

3 joint publications

Jingsong Zhang

2 joint publications

Gustavo Borjas

2 joint publications

Philippe E Spiess